# An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.

> **NCT06486948** · NA · COMPLETED · sponsor: **Click Therapeutics, Inc.** · enrollment: 58 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** CT-156

## Key facts

- **NCT ID:** NCT06486948
- **Lead sponsor:** Click Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-06
- **Primary completion:** 2024-08-09
- **Final completion:** 2024-08-09
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486948, "An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06486948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*